Sutro Biopharma (STRO) Non-Current Assets (2017 - 2026)
Sutro Biopharma (STRO) posted Non-Current Assets of $18.82 million for Q2 2026, down 38.8% from $30.73 million a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Sutro Biopharma's Non-Current Assets came in at $22.9 million, down 47.8% from FY2024.
- Annual Non-Current Assets has declined for four consecutive years, though with a five-year compound annual growth rate of 7.5% (FY2020 to FY2025).
- In prior years, Sutro Biopharma's Non-Current Assets was $43.9 million in FY2024 (-10.8%), $49.19 million in FY2023 (-8.5%), $53.79 million in FY2022 (-56.2%) and $122.89 million in FY2021 (+671.5%).
- The Q2 2026 figure stands as the lowest quarterly Non-Current Assets since Q4 2020.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q3 2021, with growth of 708.2%; the weakest was Q4 2022, with a decline of 56.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Sutro Biopharma | 265.72 Mn | -412.78 Mn | - | 18.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.82 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Sep 30, 2025 | 27.55 Mn |
| Jun 30, 2025 | 30.73 Mn |
| Mar 31, 2025 | 34.02 Mn |
| Dec 31, 2024 | 43.90 Mn |
| Sep 30, 2024 | 46.05 Mn |
| Jun 30, 2024 | 45.57 Mn |
| Mar 31, 2024 | 48.82 Mn |
| Dec 31, 2023 | 49.19 Mn |
| Sep 30, 2023 | 50.48 Mn |
| Jun 30, 2023 | 52.91 Mn |
| Mar 31, 2023 | 53.95 Mn |
| Dec 31, 2022 | 53.79 Mn |
| Sep 30, 2022 | 54.15 Mn |
| Jun 30, 2022 | 54.11 Mn |
| Mar 31, 2022 | 74.93 Mn |
| Dec 31, 2021 | 122.89 Mn |
| Sep 30, 2021 | 120.74 Mn |
| Jun 30, 2021 | 82.17 Mn |
API Access
Sutro Biopharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();